Through its new partnership with pulseData, Priority Health is striving to improve the health of persons living with chronic kidney disease (CKD)
Grand Rapids, Michigan — Chronic kidney disease, or CKD, is estimated to affect up to 37 million Americans, and through its new partnership with pulseData, Priority Health is striving to improve the health of persons living with this disease, as well as with other chronic diseases.
pulseData's artificial intelligence capabilities will gather patient data that it will then analyze and Priority Health will use to suggest CKD-related care management options. The primary end goal is to reach patients living with the disease in a more timely manner to optimize their care interventions, such as testing, medication reminders, and healthy food suggestions.
“At Priority Health, we want to make it easier for our members to take action toward their personal health journeys by providing the necessary tools and resources,” said James Forshee, MD, senior vice president and chief medical officer at Priority Health. “Our partnership with pulseData allows us to continue meeting the needs of our members through innovative data and evidence-based care solutions that will help drive better individual health outcomes.”
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More